Abstract:Photodynamic therapy (PDT) using two-photon near-infrared light excitation is a very effective way to avoid the use of short-wavelength ultraviolet or visible light which cannot efficiently penetrate into the biological tissues and is harmful to the healthy cells. Herein, a series of cyclometalated Ir(III) complexes with a structurally simple diimine ligand were designed and the synthetic route and preparation procedure were optimized, so that the complexes could be obtained in apparently higher yield, productivity, and efficiency in comparison to the traditional methods. Their ground state and excited singlet and triplet state properties were studied by spectroscopy and quantum chemistry theoretical calculations to investigate the effect of substituent groups on the photophysical properties of the complexes. The Ir(III) complexes, especially Ir1 and Ir3, showed very low dark toxicities and high phototoxicities under both one-photon and two-photon excitation, indicating their great potential as PDT agents. They were also found to be highly sensitive two-photon mitochondria dyes.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.inorgchem.0c01509?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.inorgchem.0c01509</a>.Optimized structures and frontier molecular orbitals, simulated and experimental electronic absorption spectra, cyclic voltammetry, emission spectra in aqueous solution, time-dependent changes in absorption spectra of DPBF in the presence of Ir(III) complexes, Pearson's correlation coefficient (R) analysis (PCCA) between Ir(III) complexes and MTG by CLSM on human cancer cells A549, Z-stack images of A549 stained by Ir(III) complexes, DNA-binding experiments, and experimental and computational absorption spectral data and Cartesian coordinates of the optimized structures of Ir(III) complexes for S0, S1, and T1 states (<a class="ext-link" href="/doi/suppl/10.1021/acs.inorgchem.0c01509/suppl_file/ic0c01509_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Iridium Complexes for the Application of Photodynamic Therapy

An AIE Metal Iridium Complex: Photophysical Properties and Singlet Oxygen Generation Capacity

Long-wavelength triggered iridium(III) complex nanoparticles for photodynamic therapy against hypoxic cancer

Rational design of iridium-porphyrin conjugates for novel synergistic photodynamic and photothermal therapy anticancer agents

A randomized clinical trial of feeder vessel photocoagulation of proliferative sickle cell retinopathy. I. Preliminary results.

An Iridium (III) Complex Bearing a Donor–Acceptor–Donor Type Ligand for NIR‐Triggered Dual Phototherapy

Iridium(III) Complexes Decorated with Silicane-Modified Rhodamine: Near-Infrared Light-Initiated Photosensitizers for Efficient Deep-Tissue Penetration Photodynamic Therapy

Fine-tuning the side-chain length of iridium(III) complexes for enhanced Photophysical properties in Cancer Theranostics

Dipyrrinato‐Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation

Anomeric configuration of N-acetylglucosaminyl phosphorylundecaprenols formed in Bacillus cereus Membranes.

Cyclometalated iridium(iii) complex nanoparticles for mitochondria-targeted photodynamic therapy

Disulfide-Bridged Cationic Dinuclear Ir(III) Complex with Aggregation-Induced Emission and Glutathione-Consumption Properties for Elevating Photodynamic Therapy

A Photodynamic and Photochemotherapeutic Platinum‐Iridium Charge‐Transfer Conjugate for Anticancer Therapy

Precise ligand engineering of Ir(III)-based photosensitizer with aggregation-induced emission for image-guided photodynamic therapy

Electrostatic Self-Assembled Iridium(III) Nano-Photosensitizer for Selectively Disintegrated and Mitochondria Targeted Photodynamic Therapy

[Significance of the irritability of the skin for the development of occupationally-induced allergic contact eczema].

Cyclometalated Iridium(III) Complexes as High-Sensitivity Two-Photon Excited Mitochondria Dyes and Near-Infrared Photodynamic Therapy Agents

High Photocytotoxicity Iridium(III) Complex Photosensitizer for Photodynamic Therapy Induces Antitumor Effect Through GPX4‐Dependent Ferroptosis

Cyclometalated iridium(III) tetrazine complexes for mitochondria-targeted two-photon photodynamic therapy

Rational design by DFT calculations of new metal complexes for photodynamic therapy based on an H 2 O 2 -Responsive Ir(III) photosensitizer activatable in physiological environment

Aggregation-induced emission-active iridium (III)-based mitochondria-targeting nanoparticle for two-photon imaging-guided photodynamic therapy